Phase II study of the combination of the novel bioreductive agent, tirapazamine, with cisplatin in patients with advanced non-small-cell lung cancer. (Q50506494)
Jump to navigation
Jump to search
scientific article published in December 1997
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase II study of the combination of the novel bioreductive agent, tirapazamine, with cisplatin in patients with advanced non-small-cell lung cancer. |
scientific article published in December 1997 |
Statements
Phase II study of the combination of the novel bioreductive agent, tirapazamine, with cisplatin in patients with advanced non-small-cell lung cancer. (English)
1 reference
V A Miller
1 reference
K K Ng
1 reference
S C Grant
1 reference
H Kindler
1 reference
B Pizzo
1 reference
R T Heelan
1 reference
R von Roemeling
1 reference
M G Kris
1 reference
1 December 1997
1 reference
8
1 reference
12
1 reference
1269-1271
1 reference
Identifiers
1 reference